Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as 'Tregitopes ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...